Taxifolin alleviates podocyte injury and macrophage chemotaxis associated with diabetic nephropathy by directly targeting RBP1 identified via multi-omics and machine learning
The identification of RBP1 as a novel driver of podocyte injury and macrophage chemotaxis associated with DN via multi-omics and machine learning and the potential of taxifolin as a targeted intervention for DN progression are supported.
Zi-Xuan Wang, Wen-Xuan Wang, Qiong-Dan Liang et al.
· Frontiers in Pharmacology · 0 citations